CI:NYE-Cigna Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 352.77

Change

+6.23 (+1.80)%

Market Cap

USD 35.85B

Volume

0.91M

Analyst Target

USD 242.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Cigna Corp is a health services organization. The Company provides medical, dental, disability, life and accident insurance and related products and services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-30 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 545.00B
ELV Elevance Health Inc

N/A

USD 129.14B
CNC Centene Corp

N/A

USD 41.47B
MOH Molina Healthcare Inc

N/A

USD 20.50B
OSCR Oscar Health Inc

N/A

USD 4.43B
NEUE NeueHealth Inc

N/A

USD 0.05B
CVS CVS Health Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CI

AILV 4.45 % 0.00 %

N/A

N/A
WBIL WBI BullBear Quality 3000.. 4.44 % 1.07 %

N/A

USD 0.04B
KNGU:CA Brompton U.S. Cash Flow K.. 3.87 % 0.00 %

N/A

CAD 5.99M
CBUF:F iShares V Public Limited .. 3.27 % 0.00 %

N/A

N/A
SHRY First Trust Bloomberg Sha.. 3.26 % 0.00 %

N/A

USD 0.02B
WHCS:SW iShares MSCI World Health.. 3.22 % 0.00 %

N/A

N/A
BUSA 2.38 % 0.00 %

N/A

N/A
FSST Fidelity Sustainability U.. 2.37 % 0.00 %

N/A

USD 0.01B
UVAL:SW SPDR® MSCI USA Value UCI.. 2.36 % 0.00 %

N/A

USD 0.13B
DSTL Distillate US Fundamental.. 1.64 % 0.00 %

N/A

USD 1.96B
IQSA:LSE Invesco Quantitative Stra.. 1.61 % 0.00 %

N/A

USD 0.48B
IQSA:F Invesco Markets II PLC - .. 1.53 % 0.00 %

N/A

N/A
IQSE:F Invesco Markets II PLC - .. 1.53 % 0.00 %

N/A

N/A
IFSW:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

N/A

USD 0.56B
DMFC:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.05B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A
RYH 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
UVAL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

N/A

N/A
USVL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
BUYB:PA Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

USD 0.05B
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 9.56M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.27B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.24B
BBCK:F Invesco Markets III plc -.. 0.00 % 0.00 %

N/A

USD 0.05B
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
ZPRU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.13B
BBCK:XETRA Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

USD 0.05B
IBCZ:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

USD 0.40B
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

USD 0.01B
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.40B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRU:XETRA SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.13B
IQSA:XETRA Invesco Quantitative Stra.. 0.00 % 0.00 %

N/A

USD 0.07B
IQSE:XETRA Invesco Quantitative Stra.. 0.00 % 0.00 %

N/A

USD 0.05B
HDIV 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

USD 1.13B
FDWM Fidelity Covington Trust .. 0.00 % 0.00 %

N/A

USD 4.00M
NTZG Nuveen Global Net Zero Tr.. 0.00 % 0.00 %

N/A

USD 6.58M
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.81% 88% B+ 84% B
Dividend Return 0.94% 80% B- 27% F
Total Return 18.74% 88% B+ 83% B
Trailing 12 Months  
Capital Gain 19.32% 88% B+ 80% B-
Dividend Return 1.78% 80% B- 29% F
Total Return 21.10% 88% B+ 79% B-
Trailing 5 Years  
Capital Gain 110.53% 67% D+ 88% B+
Dividend Return 9.69% 50% F 35% F
Total Return 120.23% 67% D+ 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.54% 63% D 80% B-
Dividend Return 16.94% 63% D 79% B-
Total Return 1.40% 60% D- 33% F
Risk Return Profile  
Volatility (Standard Deviation) 18.26% 88% B+ 56% F
Risk Adjusted Return 92.78% 75% C 97% N/A
Market Capitalization 35.85B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.60 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:

There is nothing we particularly dislike